| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Organ Transplantation | 50 | 2024 | 1150 | 9.960 |
Why?
|
| Kidney Transplantation | 134 | 2021 | 4215 | 7.630 |
Why?
|
| Graft Rejection | 122 | 2024 | 4423 | 6.570 |
Why?
|
| Graft Survival | 87 | 2022 | 3793 | 6.080 |
Why?
|
| Tissue Donors | 62 | 2024 | 2314 | 5.740 |
Why?
|
| Transplantation Immunology | 20 | 2018 | 532 | 3.800 |
Why?
|
| Facial Transplantation | 17 | 2021 | 221 | 3.300 |
Why?
|
| Reperfusion Injury | 25 | 2022 | 1023 | 3.280 |
Why?
|
| Immunosuppressive Agents | 60 | 2020 | 4168 | 2.730 |
Why?
|
| Brain Death | 19 | 2023 | 356 | 2.400 |
Why?
|
| Aging | 28 | 2023 | 8641 | 2.340 |
Why?
|
| Transplantation | 10 | 2024 | 218 | 2.280 |
Why?
|
| Transplantation, Homologous | 76 | 2024 | 4814 | 2.130 |
Why?
|
| Organ Preservation | 15 | 2023 | 379 | 2.030 |
Why?
|
| Uterus | 8 | 2022 | 651 | 1.960 |
Why?
|
| Rats, Inbred Lew | 71 | 2023 | 1154 | 1.870 |
Why?
|
| Tissue and Organ Procurement | 15 | 2023 | 944 | 1.850 |
Why?
|
| Immunity, Innate | 10 | 2020 | 3046 | 1.800 |
Why?
|
| Skin Transplantation | 8 | 2024 | 1083 | 1.710 |
Why?
|
| Rats, Inbred F344 | 58 | 2012 | 825 | 1.580 |
Why?
|
| Heart Transplantation | 17 | 2021 | 3217 | 1.490 |
Why?
|
| Transplantation Tolerance | 9 | 2021 | 605 | 1.480 |
Why?
|
| Infertility, Female | 6 | 2022 | 760 | 1.400 |
Why?
|
| Antilymphocyte Serum | 14 | 2020 | 482 | 1.370 |
Why?
|
| Kidney | 47 | 2024 | 7072 | 1.370 |
Why?
|
| Tissue and Organ Harvesting | 13 | 2021 | 377 | 1.360 |
Why?
|
| Awards and Prizes | 3 | 2024 | 359 | 1.200 |
Why?
|
| Adaptive Immunity | 5 | 2019 | 724 | 1.180 |
Why?
|
| Liver Transplantation | 39 | 2021 | 2317 | 1.150 |
Why?
|
| Tacrolimus | 25 | 2016 | 730 | 1.140 |
Why?
|
| Facial Injuries | 4 | 2015 | 190 | 1.130 |
Why?
|
| Cyclosporine | 25 | 2012 | 778 | 1.110 |
Why?
|
| Immune System | 7 | 2021 | 795 | 1.080 |
Why?
|
| Lymphocytes | 10 | 2020 | 2612 | 1.050 |
Why?
|
| Living Donors | 14 | 2022 | 636 | 1.040 |
Why?
|
| Heme Oxygenase (Decyclizing) | 8 | 2008 | 167 | 1.020 |
Why?
|
| Tissue Transplantation | 3 | 2016 | 128 | 0.990 |
Why?
|
| Taurodeoxycholic Acid | 2 | 2021 | 13 | 0.980 |
Why?
|
| T-Lymphocytes | 28 | 2021 | 10183 | 0.980 |
Why?
|
| Isoantibodies | 8 | 2020 | 661 | 0.980 |
Why?
|
| Mice, Inbred DBA | 7 | 2021 | 622 | 0.960 |
Why?
|
| Primary Graft Dysfunction | 2 | 2022 | 111 | 0.930 |
Why?
|
| Animals | 142 | 2024 | 167940 | 0.920 |
Why?
|
| CD4-Positive T-Lymphocytes | 10 | 2021 | 4355 | 0.920 |
Why?
|
| Perfusion | 8 | 2023 | 1376 | 0.910 |
Why?
|
| Kidney Failure, Chronic | 15 | 2020 | 2469 | 0.900 |
Why?
|
| T-Lymphocytes, Regulatory | 7 | 2021 | 3076 | 0.880 |
Why?
|
| Rats | 83 | 2023 | 23695 | 0.880 |
Why?
|
| Age Factors | 30 | 2021 | 18415 | 0.870 |
Why?
|
| NAD | 3 | 2018 | 610 | 0.870 |
Why?
|
| Valine | 2 | 2021 | 409 | 0.840 |
Why?
|
| Interferon-gamma | 12 | 2018 | 3160 | 0.800 |
Why?
|
| Interleukin-10 | 3 | 2018 | 1174 | 0.800 |
Why?
|
| Th17 Cells | 2 | 2020 | 789 | 0.790 |
Why?
|
| Renal Insufficiency | 5 | 2013 | 820 | 0.780 |
Why?
|
| Histocompatibility Testing | 8 | 2016 | 717 | 0.770 |
Why?
|
| Mice, Inbred C57BL | 28 | 2024 | 22025 | 0.770 |
Why?
|
| Bariatric Surgery | 2 | 2021 | 1006 | 0.760 |
Why?
|
| Inflammation | 15 | 2023 | 10757 | 0.720 |
Why?
|
| Quercetin | 1 | 2020 | 97 | 0.700 |
Why?
|
| Biomedical Research | 5 | 2020 | 3421 | 0.670 |
Why?
|
| Societies, Medical | 7 | 2024 | 3903 | 0.670 |
Why?
|
| Humans | 218 | 2024 | 760261 | 0.660 |
Why?
|
| Death | 6 | 2023 | 678 | 0.660 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2024 | 736 | 0.660 |
Why?
|
| Immune Tolerance | 12 | 2023 | 2299 | 0.630 |
Why?
|
| Cold Ischemia | 4 | 2018 | 67 | 0.620 |
Why?
|
| Dendritic Cells | 10 | 2024 | 2730 | 0.620 |
Why?
|
| Donor Selection | 5 | 2019 | 228 | 0.620 |
Why?
|
| Islets of Langerhans | 1 | 2024 | 1341 | 0.600 |
Why?
|
| Isoantigens | 9 | 2015 | 552 | 0.590 |
Why?
|
| Renal Circulation | 2 | 2013 | 292 | 0.580 |
Why?
|
| Hospitals, Special | 1 | 2017 | 90 | 0.560 |
Why?
|
| Lymphocyte Activation | 10 | 2021 | 5498 | 0.550 |
Why?
|
| Nephrectomy | 10 | 2018 | 1017 | 0.550 |
Why?
|
| Immunologic Memory | 4 | 2019 | 1354 | 0.550 |
Why?
|
| Transplantation, Isogeneic | 13 | 2005 | 248 | 0.540 |
Why?
|
| Gastrectomy | 1 | 2021 | 677 | 0.540 |
Why?
|
| History, 20th Century | 7 | 2024 | 2777 | 0.510 |
Why?
|
| Protoporphyrins | 7 | 2008 | 165 | 0.490 |
Why?
|
| Urogenital Abnormalities | 1 | 2018 | 256 | 0.490 |
Why?
|
| DNA, Mitochondrial | 1 | 2020 | 857 | 0.490 |
Why?
|
| Metabolome | 1 | 2021 | 976 | 0.470 |
Why?
|
| History, 21st Century | 5 | 2024 | 1576 | 0.470 |
Why?
|
| Mice | 33 | 2024 | 81216 | 0.460 |
Why?
|
| Periodicals as Topic | 2 | 2016 | 1470 | 0.460 |
Why?
|
| Writing | 1 | 2016 | 199 | 0.460 |
Why?
|
| Interleukin-17 | 3 | 2020 | 908 | 0.440 |
Why?
|
| Warm Ischemia | 2 | 2012 | 58 | 0.440 |
Why?
|
| Mice, Inbred BALB C | 9 | 2024 | 6226 | 0.430 |
Why?
|
| Fertility | 1 | 2018 | 772 | 0.430 |
Why?
|
| Time Factors | 54 | 2018 | 40133 | 0.430 |
Why?
|
| Immunoconjugates | 2 | 2020 | 949 | 0.430 |
Why?
|
| Bibliometrics | 1 | 2017 | 351 | 0.430 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2024 | 382 | 0.420 |
Why?
|
| Fetus | 1 | 2020 | 1859 | 0.410 |
Why?
|
| Pulsatile Flow | 2 | 2011 | 320 | 0.400 |
Why?
|
| Humanism | 1 | 2013 | 87 | 0.400 |
Why?
|
| Sirolimus | 3 | 2022 | 1548 | 0.400 |
Why?
|
| Heme Oxygenase-1 | 9 | 2007 | 364 | 0.400 |
Why?
|
| Organ Preservation Solutions | 4 | 2011 | 100 | 0.390 |
Why?
|
| Kidney Diseases | 6 | 2017 | 2093 | 0.390 |
Why?
|
| Postoperative Complications | 22 | 2020 | 15680 | 0.390 |
Why?
|
| Exploratory Behavior | 1 | 2013 | 273 | 0.380 |
Why?
|
| Upper Extremity | 1 | 2016 | 661 | 0.380 |
Why?
|
| Male | 122 | 2024 | 359413 | 0.380 |
Why?
|
| HLA Antigens | 7 | 2016 | 1369 | 0.370 |
Why?
|
| Ischemia | 7 | 2020 | 1893 | 0.370 |
Why?
|
| Burns, Electric | 1 | 2011 | 40 | 0.370 |
Why?
|
| Cytokines | 22 | 2023 | 7345 | 0.370 |
Why?
|
| Cryopreservation | 4 | 2010 | 720 | 0.370 |
Why?
|
| Proteinuria | 17 | 2009 | 594 | 0.360 |
Why?
|
| Frail Elderly | 1 | 2016 | 747 | 0.360 |
Why?
|
| Naphthalenes | 1 | 2011 | 198 | 0.360 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2011 | 125 | 0.360 |
Why?
|
| Lung Transplantation | 4 | 2021 | 1304 | 0.360 |
Why?
|
| Myelin Sheath | 1 | 2014 | 651 | 0.360 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 1287 | 0.360 |
Why?
|
| Blood Vessels | 1 | 2016 | 1112 | 0.360 |
Why?
|
| Steroids | 2 | 2015 | 928 | 0.350 |
Why?
|
| Skin Ulcer | 1 | 2011 | 129 | 0.350 |
Why?
|
| Methylene Chloride | 2 | 2006 | 11 | 0.350 |
Why?
|
| Tissue Survival | 2 | 2021 | 118 | 0.350 |
Why?
|
| Editorial Policies | 1 | 2015 | 457 | 0.350 |
Why?
|
| Obesity | 5 | 2023 | 12915 | 0.340 |
Why?
|
| Treatment Outcome | 40 | 2021 | 64947 | 0.340 |
Why?
|
| Plasmapheresis | 3 | 2014 | 206 | 0.340 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1490 | 0.340 |
Why?
|
| Calciphylaxis | 1 | 2011 | 130 | 0.340 |
Why?
|
| Transplants | 2 | 2021 | 206 | 0.330 |
Why?
|
| Parathyroidectomy | 1 | 2011 | 241 | 0.330 |
Why?
|
| Cell Communication | 2 | 2016 | 1642 | 0.330 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2024 | 2296 | 0.330 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2014 | 1351 | 0.330 |
Why?
|
| Reoperation | 17 | 2010 | 4292 | 0.320 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2017 | 1811 | 0.320 |
Why?
|
| Adoptive Transfer | 5 | 2016 | 825 | 0.320 |
Why?
|
| Th1 Cells | 3 | 2019 | 1033 | 0.320 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 825 | 0.320 |
Why?
|
| Carbon Monoxide | 4 | 2007 | 541 | 0.320 |
Why?
|
| Regeneration | 2 | 2014 | 1506 | 0.320 |
Why?
|
| Wnt Proteins | 1 | 2012 | 718 | 0.310 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.310 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2013 | 3735 | 0.310 |
Why?
|
| Flow Cytometry | 11 | 2018 | 5873 | 0.310 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2024 | 4554 | 0.300 |
Why?
|
| CD40 Ligand | 2 | 2022 | 522 | 0.300 |
Why?
|
| Liver Failure | 2 | 2007 | 249 | 0.300 |
Why?
|
| Antibodies, Monoclonal | 14 | 2017 | 9196 | 0.300 |
Why?
|
| Ischemic Preconditioning | 1 | 2008 | 89 | 0.300 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 2178 | 0.300 |
Why?
|
| Risk Factors | 31 | 2020 | 74269 | 0.300 |
Why?
|
| Aged | 44 | 2023 | 168995 | 0.290 |
Why?
|
| Desensitization, Immunologic | 2 | 2014 | 532 | 0.290 |
Why?
|
| Mycophenolic Acid | 7 | 2015 | 343 | 0.290 |
Why?
|
| Lymph Nodes | 6 | 2023 | 3491 | 0.290 |
Why?
|
| Antibody Formation | 3 | 2008 | 1400 | 0.280 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 1882 | 0.270 |
Why?
|
| Waiting Lists | 4 | 2021 | 754 | 0.270 |
Why?
|
| Female | 82 | 2024 | 391011 | 0.260 |
Why?
|
| Chronic Disease | 34 | 2017 | 9283 | 0.260 |
Why?
|
| Gender Identity | 2 | 2023 | 699 | 0.260 |
Why?
|
| Informed Consent | 1 | 2012 | 1007 | 0.250 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 2696 | 0.250 |
Why?
|
| Face | 3 | 2019 | 1017 | 0.250 |
Why?
|
| Europe | 3 | 2024 | 3433 | 0.250 |
Why?
|
| ABO Blood-Group System | 1 | 2007 | 369 | 0.240 |
Why?
|
| Cell Differentiation | 4 | 2020 | 11480 | 0.240 |
Why?
|
| Immunity | 2 | 2022 | 998 | 0.240 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2005 | 66 | 0.240 |
Why?
|
| Skin | 5 | 2024 | 4468 | 0.230 |
Why?
|
| Middle Aged | 63 | 2020 | 220175 | 0.230 |
Why?
|
| Adult | 62 | 2024 | 219847 | 0.230 |
Why?
|
| Mycoses | 1 | 2007 | 387 | 0.230 |
Why?
|
| Th2 Cells | 2 | 2019 | 1048 | 0.230 |
Why?
|
| Transplantation Conditioning | 3 | 2022 | 1593 | 0.230 |
Why?
|
| Patient Selection | 6 | 2020 | 4276 | 0.220 |
Why?
|
| Models, Animal | 7 | 2017 | 2117 | 0.220 |
Why?
|
| Surgical Procedures, Operative | 1 | 2015 | 1919 | 0.220 |
Why?
|
| Burns | 1 | 2015 | 1865 | 0.220 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2021 | 2536 | 0.220 |
Why?
|
| Antibodies | 5 | 2016 | 2424 | 0.210 |
Why?
|
| Health Status | 1 | 2016 | 4081 | 0.210 |
Why?
|
| Enzyme Induction | 5 | 2005 | 452 | 0.210 |
Why?
|
| Raffinose | 1 | 2002 | 53 | 0.210 |
Why?
|
| Kidney Function Tests | 5 | 2016 | 680 | 0.200 |
Why?
|
| Cobalt | 1 | 2002 | 155 | 0.200 |
Why?
|
| Antifungal Agents | 1 | 2007 | 746 | 0.200 |
Why?
|
| Hindlimb | 1 | 2024 | 510 | 0.200 |
Why?
|
| Gene Expression Profiling | 6 | 2024 | 9388 | 0.200 |
Why?
|
| Methylprednisolone | 4 | 2009 | 384 | 0.200 |
Why?
|
| Live Birth | 3 | 2022 | 512 | 0.190 |
Why?
|
| Aging, Premature | 1 | 2021 | 45 | 0.190 |
Why?
|
| Intercellular Adhesion Molecule-1 | 12 | 2010 | 1128 | 0.190 |
Why?
|
| Receptors, Interleukin-2 | 5 | 2003 | 562 | 0.190 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 18134 | 0.190 |
Why?
|
| Allopurinol | 1 | 2002 | 200 | 0.180 |
Why?
|
| Injections, Intraperitoneal | 1 | 2021 | 413 | 0.180 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 3 | 2021 | 305 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5644 | 0.180 |
Why?
|
| Complement System Proteins | 2 | 2014 | 782 | 0.180 |
Why?
|
| Mice, Obese | 1 | 2021 | 420 | 0.180 |
Why?
|
| Receptors, Leptin | 1 | 2022 | 350 | 0.180 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2021 | 619 | 0.180 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2020 | 34 | 0.180 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2023 | 268 | 0.170 |
Why?
|
| Interleukin-6 | 6 | 2018 | 3207 | 0.170 |
Why?
|
| Preoperative Care | 3 | 2010 | 2255 | 0.170 |
Why?
|
| Gene Expression | 7 | 2018 | 7592 | 0.170 |
Why?
|
| Cells, Cultured | 7 | 2017 | 18968 | 0.170 |
Why?
|
| Ureteral Obstruction | 1 | 2021 | 292 | 0.170 |
Why?
|
| Glutathione | 1 | 2002 | 582 | 0.170 |
Why?
|
| Medication Adherence | 1 | 2011 | 2163 | 0.170 |
Why?
|
| Mullerian Ducts | 1 | 2020 | 201 | 0.170 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3202 | 0.170 |
Why?
|
| Risk Assessment | 10 | 2019 | 24086 | 0.170 |
Why?
|
| Carrier Proteins | 1 | 2012 | 4938 | 0.170 |
Why?
|
| Mice, Knockout | 6 | 2017 | 14396 | 0.160 |
Why?
|
| Sex Characteristics | 4 | 2019 | 2627 | 0.160 |
Why?
|
| Glucose Intolerance | 1 | 2023 | 579 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2010 | 4573 | 0.160 |
Why?
|
| End Stage Liver Disease | 1 | 2023 | 347 | 0.160 |
Why?
|
| Wounds and Injuries | 1 | 2011 | 2477 | 0.160 |
Why?
|
| Liver | 7 | 2021 | 7512 | 0.160 |
Why?
|
| Hyperammonemia | 1 | 2019 | 77 | 0.160 |
Why?
|
| Signal Transduction | 6 | 2022 | 23363 | 0.160 |
Why?
|
| United States | 17 | 2022 | 72363 | 0.160 |
Why?
|
| Hand-Assisted Laparoscopy | 1 | 2018 | 16 | 0.160 |
Why?
|
| Gift Giving | 1 | 2018 | 76 | 0.150 |
Why?
|
| Follow-Up Studies | 30 | 2023 | 39254 | 0.150 |
Why?
|
| Epigenomics | 1 | 2024 | 936 | 0.150 |
Why?
|
| Antigen Presentation | 2 | 2021 | 1254 | 0.150 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2023 | 975 | 0.150 |
Why?
|
| Embryo Implantation | 1 | 2020 | 270 | 0.150 |
Why?
|
| Primates | 1 | 2020 | 523 | 0.150 |
Why?
|
| Resource Allocation | 1 | 2020 | 349 | 0.150 |
Why?
|
| Stem Cells | 2 | 2024 | 3525 | 0.150 |
Why?
|
| Interleukins | 4 | 2009 | 782 | 0.150 |
Why?
|
| Survival Analysis | 13 | 2014 | 10185 | 0.150 |
Why?
|
| Retroperitoneal Space | 1 | 2018 | 173 | 0.150 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2017 | 43 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2022 | 821 | 0.140 |
Why?
|
| Estradiol | 2 | 2021 | 1932 | 0.140 |
Why?
|
| Adenosine | 1 | 2002 | 833 | 0.140 |
Why?
|
| Lymphocyte Transfusion | 1 | 1998 | 232 | 0.140 |
Why?
|
| Cytomegalovirus Infections | 3 | 2012 | 831 | 0.140 |
Why?
|
| Cold Temperature | 3 | 2010 | 780 | 0.140 |
Why?
|
| Histocompatibility | 2 | 2017 | 316 | 0.140 |
Why?
|
| Altruism | 1 | 2018 | 204 | 0.140 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2016 | 57 | 0.140 |
Why?
|
| Gene Expression Regulation | 9 | 2021 | 11902 | 0.140 |
Why?
|
| HLA-DR1 Antigen | 1 | 2016 | 12 | 0.140 |
Why?
|
| Cell Movement | 6 | 2018 | 5206 | 0.130 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2016 | 30 | 0.130 |
Why?
|
| Stromal Cells | 1 | 2022 | 1327 | 0.130 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2016 | 25 | 0.130 |
Why?
|
| Chemokine CCL3 | 1 | 2016 | 84 | 0.130 |
Why?
|
| Thalidomide | 1 | 2021 | 884 | 0.130 |
Why?
|
| Acute Disease | 11 | 2017 | 7268 | 0.130 |
Why?
|
| International Cooperation | 3 | 2020 | 1436 | 0.130 |
Why?
|
| Histocompatibility Antigens Class II | 6 | 2005 | 1446 | 0.130 |
Why?
|
| Prednisolone | 6 | 2003 | 328 | 0.130 |
Why?
|
| Pancreas | 1 | 2002 | 1677 | 0.130 |
Why?
|
| Pregnancy | 5 | 2022 | 29725 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 704 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2020 | 804 | 0.120 |
Why?
|
| Mice, Inbred CBA | 1 | 2016 | 436 | 0.120 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 2218 | 0.120 |
Why?
|
| Mice, Transgenic | 4 | 2018 | 9531 | 0.120 |
Why?
|
| Monitoring, Immunologic | 1 | 2015 | 98 | 0.120 |
Why?
|
| Antigens | 2 | 2016 | 1447 | 0.120 |
Why?
|
| Hepatectomy | 4 | 2014 | 560 | 0.120 |
Why?
|
| Metabolomics | 1 | 2024 | 1626 | 0.120 |
Why?
|
| Ferrosoferric Oxide | 1 | 2016 | 348 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2023 | 1380 | 0.120 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2016 | 226 | 0.120 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2018 | 479 | 0.120 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2014 | 94 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 8 | 1994 | 1602 | 0.120 |
Why?
|
| Killer Cells, Natural | 3 | 2016 | 2204 | 0.120 |
Why?
|
| Endothelium, Vascular | 3 | 2018 | 4437 | 0.120 |
Why?
|
| Anastomosis, Surgical | 2 | 2010 | 983 | 0.120 |
Why?
|
| Homeostasis | 2 | 2016 | 3305 | 0.120 |
Why?
|
| Immunoglobulins | 3 | 2012 | 863 | 0.110 |
Why?
|
| Amputees | 1 | 2014 | 84 | 0.110 |
Why?
|
| Graft vs Host Reaction | 1 | 2014 | 103 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2018 | 1531 | 0.110 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 657 | 0.110 |
Why?
|
| Health Status Disparities | 2 | 2019 | 1819 | 0.110 |
Why?
|
| Phenotype | 3 | 2019 | 16543 | 0.110 |
Why?
|
| MicroRNAs | 4 | 2016 | 3784 | 0.110 |
Why?
|
| Cell Adhesion | 3 | 2010 | 3096 | 0.110 |
Why?
|
| Capillaries | 1 | 2016 | 745 | 0.110 |
Why?
|
| Vascular Grafting | 1 | 2015 | 153 | 0.110 |
Why?
|
| Allergy and Immunology | 1 | 2015 | 175 | 0.110 |
Why?
|
| Brazil | 1 | 2017 | 1214 | 0.110 |
Why?
|
| DNA | 2 | 2023 | 7236 | 0.110 |
Why?
|
| Complement Activation | 2 | 2012 | 446 | 0.110 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 730 | 0.110 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 530 | 0.110 |
Why?
|
| Surgical Wound Infection | 2 | 2012 | 1529 | 0.110 |
Why?
|
| Clinical Trials as Topic | 3 | 2019 | 8058 | 0.100 |
Why?
|
| Polymers | 1 | 2020 | 1620 | 0.100 |
Why?
|
| Consensus | 2 | 2020 | 3106 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3086 | 0.100 |
Why?
|
| Informed Consent By Minors | 1 | 2012 | 9 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3206 | 0.100 |
Why?
|
| Transplantation Chimera | 2 | 2013 | 595 | 0.100 |
Why?
|
| Prognosis | 13 | 2019 | 29636 | 0.100 |
Why?
|
| Delayed Graft Function | 2 | 2010 | 49 | 0.100 |
Why?
|
| Glucocorticoids | 4 | 2011 | 2143 | 0.100 |
Why?
|
| Hepatitis B | 4 | 2002 | 701 | 0.100 |
Why?
|
| Anesthesia | 2 | 2014 | 1584 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2020 | 4357 | 0.100 |
Why?
|
| Rats, Inbred Strains | 3 | 2009 | 2094 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 2138 | 0.100 |
Why?
|
| Access to Information | 1 | 2015 | 320 | 0.100 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2011 | 123 | 0.100 |
Why?
|
| Hemodynamics | 2 | 2012 | 4169 | 0.100 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 2 | 2006 | 196 | 0.100 |
Why?
|
| Immunohistochemistry | 12 | 2014 | 11064 | 0.100 |
Why?
|
| Seasons | 1 | 2017 | 1523 | 0.100 |
Why?
|
| Lymphocyte Depletion | 1 | 2013 | 602 | 0.090 |
Why?
|
| Intestines | 1 | 2020 | 1907 | 0.090 |
Why?
|
| Endocrine System | 1 | 2012 | 112 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 6 | 2020 | 2297 | 0.090 |
Why?
|
| Laboratories | 1 | 2015 | 461 | 0.090 |
Why?
|
| Antigens, CD | 7 | 2012 | 4002 | 0.090 |
Why?
|
| Rats, Inbred BN | 2 | 2002 | 231 | 0.090 |
Why?
|
| Insulin | 3 | 2002 | 6592 | 0.090 |
Why?
|
| Registries | 4 | 2020 | 8449 | 0.090 |
Why?
|
| Mast Cells | 1 | 2018 | 1428 | 0.090 |
Why?
|
| Patient Preference | 1 | 2018 | 921 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 2058 | 0.090 |
Why?
|
| Immunocompetence | 1 | 2010 | 137 | 0.090 |
Why?
|
| Uremia | 1 | 2011 | 201 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2014 | 1314 | 0.090 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 795 | 0.090 |
Why?
|
| Rosacea | 1 | 2011 | 59 | 0.090 |
Why?
|
| Thigh | 1 | 2011 | 239 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 857 | 0.090 |
Why?
|
| Weight Loss | 1 | 2021 | 2683 | 0.090 |
Why?
|
| Liver Neoplasms | 7 | 2020 | 4317 | 0.090 |
Why?
|
| Procaine | 1 | 2010 | 60 | 0.090 |
Why?
|
| Blood Group Incompatibility | 1 | 2010 | 135 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2016 | 1536 | 0.090 |
Why?
|
| Lipids | 1 | 2021 | 3336 | 0.090 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2012 | 900 | 0.090 |
Why?
|
| Lymphocele | 1 | 2009 | 19 | 0.090 |
Why?
|
| RNA, Messenger | 10 | 2010 | 12762 | 0.090 |
Why?
|
| Complement C3 | 2 | 2010 | 451 | 0.090 |
Why?
|
| Acute Kidney Injury | 2 | 2016 | 1935 | 0.090 |
Why?
|
| Cadaver | 3 | 2010 | 1345 | 0.090 |
Why?
|
| Healthcare Disparities | 2 | 2019 | 3381 | 0.090 |
Why?
|
| Drug Therapy, Combination | 12 | 2005 | 6499 | 0.080 |
Why?
|
| Personal Autonomy | 1 | 2012 | 302 | 0.080 |
Why?
|
| Berlin | 1 | 2009 | 23 | 0.080 |
Why?
|
| Potassium Chloride | 1 | 2010 | 233 | 0.080 |
Why?
|
| Membrane Proteins | 4 | 2021 | 7854 | 0.080 |
Why?
|
| Mannitol | 1 | 2010 | 180 | 0.080 |
Why?
|
| BK Virus | 1 | 2010 | 124 | 0.080 |
Why?
|
| Ubiquitin | 1 | 2014 | 840 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 1335 | 0.080 |
Why?
|
| Pancreas Transplantation | 1 | 2010 | 196 | 0.080 |
Why?
|
| Forecasting | 1 | 2018 | 2931 | 0.080 |
Why?
|
| Isoflurane | 1 | 2012 | 384 | 0.080 |
Why?
|
| Creatinine | 7 | 2016 | 1906 | 0.080 |
Why?
|
| Lectins, C-Type | 1 | 2012 | 591 | 0.080 |
Why?
|
| Motivation | 1 | 2018 | 1990 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 12156 | 0.080 |
Why?
|
| Epithelial Cells | 3 | 2024 | 3665 | 0.080 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2014 | 664 | 0.080 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 1405 | 0.080 |
Why?
|
| Liver Cirrhosis | 5 | 2002 | 1925 | 0.080 |
Why?
|
| Fluoroquinolones | 1 | 2010 | 309 | 0.080 |
Why?
|
| Polyomavirus Infections | 1 | 2010 | 195 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 2866 | 0.080 |
Why?
|
| Cadherins | 1 | 2012 | 898 | 0.080 |
Why?
|
| Ureter | 1 | 2010 | 375 | 0.080 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 1601 | 0.070 |
Why?
|
| Fibroblasts | 2 | 2022 | 4091 | 0.070 |
Why?
|
| Leadership | 1 | 2017 | 1372 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2012 | 914 | 0.070 |
Why?
|
| Retrospective Studies | 30 | 2021 | 80301 | 0.070 |
Why?
|
| beta Catenin | 1 | 2012 | 1043 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2008 | 1799 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2003 | 943 | 0.070 |
Why?
|
| Ventilator Weaning | 1 | 2008 | 161 | 0.070 |
Why?
|
| Necrosis | 1 | 2011 | 1612 | 0.070 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 15273 | 0.070 |
Why?
|
| Common Bile Duct | 1 | 2007 | 106 | 0.070 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 566 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2017 | 2058 | 0.070 |
Why?
|
| Antigens, Surface | 3 | 2016 | 1616 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2016 | 1589 | 0.070 |
Why?
|
| Germany | 1 | 2009 | 875 | 0.070 |
Why?
|
| Endothelium | 2 | 2022 | 764 | 0.070 |
Why?
|
| Receptors, Chemokine | 1 | 2010 | 654 | 0.070 |
Why?
|
| Carboxyhemoglobin | 1 | 2006 | 80 | 0.070 |
Why?
|
| Duodenal Diseases | 1 | 2007 | 99 | 0.070 |
Why?
|
| Lung | 2 | 2022 | 9989 | 0.070 |
Why?
|
| Lymphocyte Subsets | 2 | 1998 | 310 | 0.070 |
Why?
|
| Contrast Media | 3 | 2016 | 5301 | 0.070 |
Why?
|
| Muromegalovirus | 1 | 2006 | 31 | 0.070 |
Why?
|
| Immunologic Techniques | 2 | 2003 | 213 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 2414 | 0.070 |
Why?
|
| Information Dissemination | 1 | 2015 | 1132 | 0.070 |
Why?
|
| Treatment Failure | 2 | 2002 | 2646 | 0.070 |
Why?
|
| Autophagy | 1 | 2014 | 1336 | 0.070 |
Why?
|
| Ketamine | 1 | 2012 | 516 | 0.070 |
Why?
|
| Cholangitis | 1 | 2007 | 113 | 0.070 |
Why?
|
| Pyrazines | 1 | 2012 | 1200 | 0.070 |
Why?
|
| Surgical Flaps | 1 | 2015 | 1666 | 0.070 |
Why?
|
| Blood Coagulation | 1 | 2012 | 1156 | 0.070 |
Why?
|
| Diverticulum | 1 | 2007 | 137 | 0.070 |
Why?
|
| Bacterial Infections | 3 | 2002 | 1402 | 0.060 |
Why?
|
| Azathioprine | 4 | 2000 | 356 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1998 | 459 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 3 | 2021 | 1956 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 3804 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 2424 | 0.060 |
Why?
|
| Boston | 3 | 2014 | 9282 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2017 | 1938 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 5 | 2020 | 2178 | 0.060 |
Why?
|
| Wound Healing | 1 | 2016 | 2786 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2018 | 3257 | 0.060 |
Why?
|
| Actins | 1 | 2012 | 2049 | 0.060 |
Why?
|
| Toll-Like Receptors | 1 | 2008 | 590 | 0.060 |
Why?
|
| Hemoperfusion | 1 | 2004 | 13 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 2235 | 0.060 |
Why?
|
| Young Adult | 7 | 2018 | 58673 | 0.060 |
Why?
|
| Cohort Studies | 5 | 2018 | 41317 | 0.060 |
Why?
|
| Pandemics | 5 | 2022 | 8621 | 0.060 |
Why?
|
| Hyperbilirubinemia | 1 | 2004 | 74 | 0.060 |
Why?
|
| Survival Rate | 13 | 2013 | 12806 | 0.060 |
Why?
|
| Bilirubin | 2 | 2004 | 438 | 0.060 |
Why?
|
| Macrophages | 8 | 2003 | 5745 | 0.060 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2005 | 334 | 0.060 |
Why?
|
| Perception | 1 | 2010 | 1194 | 0.060 |
Why?
|
| Bacterial Translocation | 1 | 2004 | 73 | 0.060 |
Why?
|
| Antiviral Agents | 2 | 2010 | 3061 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 3967 | 0.060 |
Why?
|
| Lymphocyte Count | 2 | 2003 | 780 | 0.060 |
Why?
|
| Mice, Nude | 1 | 2010 | 3605 | 0.050 |
Why?
|
| Minority Groups | 1 | 2010 | 1199 | 0.050 |
Why?
|
| Drug Administration Schedule | 4 | 2005 | 4900 | 0.050 |
Why?
|
| Caroli Disease | 1 | 2002 | 13 | 0.050 |
Why?
|
| Hypertension, Renal | 1 | 2003 | 141 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2013 | 2982 | 0.050 |
Why?
|
| Interleukin-2 | 3 | 2008 | 1890 | 0.050 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2002 | 24 | 0.050 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2005 | 172 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2022 | 26168 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5324 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2874 | 0.050 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2002 | 141 | 0.050 |
Why?
|
| 2-Aminopurine | 1 | 2001 | 11 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2003 | 256 | 0.050 |
Why?
|
| Hypotension | 1 | 2008 | 883 | 0.050 |
Why?
|
| Simvastatin | 2 | 2018 | 352 | 0.050 |
Why?
|
| Rats, Inbred WF | 3 | 1998 | 138 | 0.050 |
Why?
|
| Goiter, Nodular | 1 | 2001 | 28 | 0.050 |
Why?
|
| Renal Artery | 3 | 2016 | 368 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 1169 | 0.050 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2022 | 50 | 0.050 |
Why?
|
| Metabolic Diseases | 2 | 1999 | 685 | 0.050 |
Why?
|
| Dystrophin | 1 | 2023 | 284 | 0.050 |
Why?
|
| Myoblasts | 1 | 2023 | 235 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 58947 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2018 | 503 | 0.050 |
Why?
|
| Venules | 1 | 2022 | 164 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2016 | 3327 | 0.050 |
Why?
|
| Child | 5 | 2021 | 79758 | 0.050 |
Why?
|
| Ice | 1 | 2002 | 102 | 0.050 |
Why?
|
| Freezing | 1 | 2002 | 306 | 0.050 |
Why?
|
| Blood Pressure | 4 | 2012 | 8523 | 0.050 |
Why?
|
| Crystallization | 1 | 2002 | 533 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2008 | 1328 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4739 | 0.050 |
Why?
|
| Comorbidity | 1 | 2015 | 10552 | 0.050 |
Why?
|
| Adolescent | 10 | 2014 | 87747 | 0.050 |
Why?
|
| Pituitary Hormones | 1 | 2002 | 182 | 0.050 |
Why?
|
| Kidney Tubules | 3 | 2010 | 449 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 3159 | 0.050 |
Why?
|
| Membrane Glycoproteins | 2 | 2021 | 3731 | 0.050 |
Why?
|
| STAT5 Transcription Factor | 1 | 2021 | 264 | 0.050 |
Why?
|
| Hyperthermia, Induced | 1 | 2004 | 415 | 0.040 |
Why?
|
| Prednisone | 1 | 2005 | 1566 | 0.040 |
Why?
|
| Extracellular Matrix | 2 | 2022 | 1726 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 584 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 3726 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2003 | 584 | 0.040 |
Why?
|
| Probiotics | 1 | 2004 | 377 | 0.040 |
Why?
|
| Angiography | 1 | 2005 | 1605 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2024 | 547 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2003 | 649 | 0.040 |
Why?
|
| Propionates | 1 | 2000 | 182 | 0.040 |
Why?
|
| Liver Function Tests | 4 | 2005 | 524 | 0.040 |
Why?
|
| Pancreatitis | 1 | 2007 | 1100 | 0.040 |
Why?
|
| C-Peptide | 2 | 1999 | 433 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2002 | 724 | 0.040 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1999 | 51 | 0.040 |
Why?
|
| Hepatic Duct, Common | 1 | 1999 | 48 | 0.040 |
Why?
|
| Radiographic Image Enhancement | 2 | 2016 | 880 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2671 | 0.040 |
Why?
|
| Luteinizing Hormone | 1 | 2002 | 820 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 12532 | 0.040 |
Why?
|
| Belgium | 1 | 2019 | 118 | 0.040 |
Why?
|
| Financing, Organized | 1 | 2020 | 204 | 0.040 |
Why?
|
| Pituitary Gland | 1 | 2002 | 637 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10434 | 0.040 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1999 | 118 | 0.040 |
Why?
|
| Fibrosis | 3 | 2021 | 2042 | 0.040 |
Why?
|
| Cognition | 1 | 2016 | 6948 | 0.040 |
Why?
|
| Prevalence | 2 | 2013 | 15687 | 0.040 |
Why?
|
| Muromonab-CD3 | 1 | 1998 | 104 | 0.040 |
Why?
|
| Creatine | 1 | 2000 | 426 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 2001 | 928 | 0.040 |
Why?
|
| Transplantation, Heterotopic | 1 | 2018 | 174 | 0.040 |
Why?
|
| Glucose | 1 | 2010 | 4361 | 0.040 |
Why?
|
| Recurrence | 5 | 2017 | 8487 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 1173 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 751 | 0.040 |
Why?
|
| Sex Factors | 2 | 2023 | 10530 | 0.040 |
Why?
|
| Lymphatic Vessels | 1 | 2022 | 358 | 0.040 |
Why?
|
| DNA, Complementary | 3 | 2007 | 1993 | 0.040 |
Why?
|
| Hormones | 1 | 2021 | 867 | 0.040 |
Why?
|
| Listeriosis | 1 | 2018 | 148 | 0.040 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 1995 | 377 | 0.030 |
Why?
|
| Liver Failure, Acute | 1 | 1998 | 181 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 7593 | 0.030 |
Why?
|
| Incidence | 7 | 2020 | 21378 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2011 | 12901 | 0.030 |
Why?
|
| Postoperative Period | 3 | 2008 | 1821 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2001 | 903 | 0.030 |
Why?
|
| Listeria monocytogenes | 1 | 2018 | 249 | 0.030 |
Why?
|
| Colon | 1 | 2004 | 1788 | 0.030 |
Why?
|
| Cell Line | 2 | 2022 | 15626 | 0.030 |
Why?
|
| Sweden | 1 | 2019 | 1381 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2002 | 721 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 20484 | 0.030 |
Why?
|
| China | 1 | 2022 | 2340 | 0.030 |
Why?
|
| Research Personnel | 1 | 2020 | 584 | 0.030 |
Why?
|
| Censuses | 1 | 2017 | 201 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2002 | 1870 | 0.030 |
Why?
|
| Biopsy | 3 | 2013 | 6775 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2003 | 1802 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 3443 | 0.030 |
Why?
|
| Health Care Rationing | 1 | 2018 | 435 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2004 | 8157 | 0.030 |
Why?
|
| Transplantation, Autologous | 2 | 2016 | 2120 | 0.030 |
Why?
|
| Internationality | 1 | 2020 | 1005 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2001 | 2195 | 0.030 |
Why?
|
| Hysterectomy | 1 | 2020 | 901 | 0.030 |
Why?
|
| Blotting, Western | 3 | 2010 | 5039 | 0.030 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2019 | 498 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2016 | 652 | 0.030 |
Why?
|
| Polyesters | 1 | 2016 | 372 | 0.030 |
Why?
|
| Rabbits | 2 | 2011 | 4773 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3466 | 0.030 |
Why?
|
| Occupational Health | 1 | 2020 | 804 | 0.030 |
Why?
|
| Blood Glucose | 2 | 1999 | 6375 | 0.030 |
Why?
|
| Organ Size | 3 | 2012 | 2249 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1995 | 1143 | 0.030 |
Why?
|
| Kidney Glomerulus | 4 | 1999 | 568 | 0.030 |
Why?
|
| Combined Modality Therapy | 3 | 2014 | 8551 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2014 | 201 | 0.030 |
Why?
|
| Mutation | 2 | 2017 | 29950 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 544 | 0.030 |
Why?
|
| Jejunostomy | 2 | 2007 | 59 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 2004 | 1423 | 0.030 |
Why?
|
| Bile Duct Neoplasms | 1 | 1999 | 600 | 0.030 |
Why?
|
| Nephrons | 1 | 1994 | 168 | 0.030 |
Why?
|
| Thermosensing | 1 | 2013 | 55 | 0.030 |
Why?
|
| Vaccines | 1 | 2002 | 833 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 896 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 934 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 732 | 0.030 |
Why?
|
| Prospective Studies | 7 | 2021 | 54263 | 0.030 |
Why?
|
| Microspheres | 1 | 2016 | 785 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2008 | 3217 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1617 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2015 | 429 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2018 | 1666 | 0.030 |
Why?
|
| Receptors, Immunologic | 2 | 2016 | 1434 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 1340 | 0.030 |
Why?
|
| Models, Immunological | 1 | 1995 | 513 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2014 | 2473 | 0.030 |
Why?
|
| Radioisotope Renography | 1 | 2012 | 61 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 1997 | 1122 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2014 | 0.030 |
Why?
|
| Carcinoma | 1 | 2004 | 2334 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 943 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6545 | 0.020 |
Why?
|
| Exosomes | 1 | 2016 | 423 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 728 | 0.020 |
Why?
|
| Quality of Life | 3 | 2021 | 13300 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 2010 | 1705 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1995 | 560 | 0.020 |
Why?
|
| Hepatitis C, Chronic | 1 | 2020 | 1031 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1994 | 663 | 0.020 |
Why?
|
| Atrophy | 2 | 1994 | 1625 | 0.020 |
Why?
|
| Pyrimidines | 2 | 2000 | 3011 | 0.020 |
Why?
|
| Length of Stay | 2 | 2018 | 6472 | 0.020 |
Why?
|
| Immunity, Cellular | 2 | 2014 | 1558 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2023 | 3561 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 693 | 0.020 |
Why?
|
| Chemokine CCL19 | 1 | 2010 | 35 | 0.020 |
Why?
|
| Touch | 1 | 2013 | 312 | 0.020 |
Why?
|
| Chemokine CCL21 | 1 | 2010 | 51 | 0.020 |
Why?
|
| Cause of Death | 1 | 2001 | 3723 | 0.020 |
Why?
|
| Testosterone | 1 | 2002 | 2469 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2014 | 1849 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 2651 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2020 | 1940 | 0.020 |
Why?
|
| Receptor, Endothelin A | 2 | 2000 | 56 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1999 | 1301 | 0.020 |
Why?
|
| Receptors, Complement | 1 | 2010 | 253 | 0.020 |
Why?
|
| Endothelins | 2 | 2000 | 127 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2010 | 183 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2010 | 426 | 0.020 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 272 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 1997 | 1060 | 0.020 |
Why?
|
| Protective Agents | 1 | 2010 | 150 | 0.020 |
Why?
|
| Tissue Preservation | 1 | 2010 | 174 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 1828 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 1997 | 2202 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 36247 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4127 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 939 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 2012 | 756 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 2906 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 1933 | 0.020 |
Why?
|
| Hypertension | 3 | 2004 | 8595 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1500 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2128 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2014 | 2434 | 0.020 |
Why?
|
| Viremia | 1 | 2010 | 708 | 0.020 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2007 | 86 | 0.020 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2008 | 183 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6242 | 0.020 |
Why?
|
| Lower Extremity | 1 | 2014 | 1196 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 5784 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2009 | 674 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2008 | 607 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2006 | 187 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 2596 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2014 | 879 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5201 | 0.020 |
Why?
|
| Renal Veins | 1 | 2005 | 102 | 0.020 |
Why?
|
| Glucose Tolerance Test | 2 | 1999 | 1174 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 982 | 0.020 |
Why?
|
| Disease Progression | 2 | 2004 | 13505 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 2394 | 0.020 |
Why?
|
| Safety | 1 | 2010 | 1149 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 1670 | 0.020 |
Why?
|
| Neoplasms | 4 | 2014 | 22066 | 0.010 |
Why?
|
| Probability | 1 | 2010 | 2476 | 0.010 |
Why?
|
| Adsorption | 1 | 2004 | 197 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2007 | 505 | 0.010 |
Why?
|
| Peritoneal Lavage | 1 | 2004 | 31 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2852 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 1097 | 0.010 |
Why?
|
| Administration, Oral | 2 | 2004 | 4044 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2010 | 1511 | 0.010 |
Why?
|
| Desoxycorticosterone | 1 | 2003 | 46 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 4409 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2004 | 328 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1999 | 4024 | 0.010 |
Why?
|
| Neutrophils | 2 | 1994 | 3770 | 0.010 |
Why?
|
| Cecum | 1 | 2004 | 232 | 0.010 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2003 | 33 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11708 | 0.010 |
Why?
|
| Ions | 1 | 2004 | 261 | 0.010 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2003 | 57 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15827 | 0.010 |
Why?
|
| Aorta | 1 | 2010 | 2042 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 1663 | 0.010 |
Why?
|
| Lactobacillus | 1 | 2004 | 204 | 0.010 |
Why?
|
| Organoplatinum Compounds | 1 | 2004 | 410 | 0.010 |
Why?
|
| Spleen | 2 | 2002 | 2298 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2010 | 988 | 0.010 |
Why?
|
| Adenoviridae Infections | 1 | 2003 | 93 | 0.010 |
Why?
|
| Liver Regeneration | 1 | 2004 | 213 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5782 | 0.010 |
Why?
|
| Leucovorin | 1 | 2004 | 639 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 8945 | 0.010 |
Why?
|
| Pelvic Neoplasms | 1 | 2004 | 248 | 0.010 |
Why?
|
| Permeability | 1 | 2004 | 719 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2018 | 3524 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 2001 | 134 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2004 | 796 | 0.010 |
Why?
|
| Blood | 1 | 2004 | 586 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2002 | 235 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 6181 | 0.010 |
Why?
|
| Pneumonia | 1 | 2012 | 2138 | 0.010 |
Why?
|
| Viral Load | 1 | 2010 | 3323 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2004 | 599 | 0.010 |
Why?
|
| Receptor, Endothelin B | 1 | 2000 | 46 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1972 | 0.010 |
Why?
|
| Hypocalcemia | 1 | 2001 | 199 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 1328 | 0.010 |
Why?
|
| Lamivudine | 1 | 2001 | 363 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25928 | 0.010 |
Why?
|
| Myocardium | 1 | 2013 | 4688 | 0.010 |
Why?
|
| Receptors, Endothelin | 1 | 1999 | 56 | 0.010 |
Why?
|
| Prolactin | 1 | 2002 | 621 | 0.010 |
Why?
|
| Heart | 1 | 2013 | 4392 | 0.010 |
Why?
|
| Phenylpropionates | 1 | 1999 | 35 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2000 | 451 | 0.010 |
Why?
|
| GTPase-Activating Proteins | 1 | 2002 | 475 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3774 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2004 | 1630 | 0.010 |
Why?
|
| Disease-Free Survival | 2 | 2001 | 6830 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 1193 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1998 | 114 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 1084 | 0.010 |
Why?
|
| Algorithms | 2 | 2013 | 13967 | 0.010 |
Why?
|
| Vocal Cord Paralysis | 1 | 2001 | 272 | 0.010 |
Why?
|
| Lipopolysaccharides | 2 | 1996 | 2214 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 4923 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 1999 | 302 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1998 | 375 | 0.010 |
Why?
|
| Lymphoma | 2 | 1997 | 1899 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7468 | 0.010 |
Why?
|
| Nervous System Diseases | 2 | 1998 | 1647 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 2721 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2004 | 1228 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1998 | 630 | 0.010 |
Why?
|
| Brain | 1 | 2023 | 26912 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1998 | 2186 | 0.010 |
Why?
|
| Rectal Neoplasms | 1 | 2004 | 1151 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2004 | 9274 | 0.010 |
Why?
|
| Computer Simulation | 2 | 1999 | 6210 | 0.010 |
Why?
|
| Cross Infection | 1 | 2004 | 1434 | 0.010 |
Why?
|
| Monocytes | 2 | 1994 | 2574 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 14482 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 9497 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 2819 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2002 | 1920 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 20048 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2002 | 1798 | 0.010 |
Why?
|
| Menopause | 1 | 2002 | 1640 | 0.010 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 1997 | 387 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2004 | 2918 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 3378 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2004 | 4891 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1994 | 287 | 0.010 |
Why?
|
| Postmenopause | 1 | 2002 | 2503 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 1997 | 782 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 6067 | 0.010 |
Why?
|
| Morbidity | 1 | 1997 | 1765 | 0.010 |
Why?
|
| Bone Density | 1 | 2005 | 3528 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1996 | 829 | 0.010 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1994 | 325 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 5884 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1997 | 2569 | 0.010 |
Why?
|
| Triglycerides | 1 | 1998 | 2476 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14656 | 0.010 |
Why?
|
| Fibrin | 1 | 1993 | 505 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1994 | 1250 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 1993 | 912 | 0.010 |
Why?
|
| Cholesterol | 1 | 1998 | 2925 | 0.010 |
Why?
|
| Integrins | 1 | 1993 | 840 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1993 | 1529 | 0.000 |
Why?
|
| Base Sequence | 1 | 1998 | 12447 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 13456 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 6310 | 0.000 |
Why?
|
| Hepatitis C | 1 | 1996 | 1578 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 17628 | 0.000 |
Why?
|
| Child, Preschool | 2 | 1999 | 42034 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 12281 | 0.000 |
Why?
|
| Leukocytes | 1 | 1993 | 2030 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1997 | 2018 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 12968 | 0.000 |
Why?
|
| Models, Biological | 1 | 1998 | 9468 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 13629 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1997 | 10340 | 0.000 |
Why?
|
| Skin Neoplasms | 1 | 1997 | 5797 | 0.000 |
Why?
|